A Registry for People With Lung Cancer

Purpose

Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.

Conditions

  • Lung Cancer
  • Lung Cancer Stage I

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥18 years - Patients suitable for segmentectomy, according to the treating surgeon - Clinical Stage I with suspected NSCLC, classified preoperatively based on the AJCC TNM staging manual, 9th edition o Note: Tissue diagnosis of NSCLC is not required before enrollment. A pathologic diagnosis of NSCLC may be confirmed preoperatively with biopsy, intraoperatively with frozen section, or postoperatively on final pathology

Exclusion Criteria

  • Actively receiving lung cancer treatment or a history of lung cancer in the previous 5 years - History of chemotherapy or radiation therapy for a previous lung cancer - Synchronous secondary cancer in the lung or elsewhere in the body at the time of surgery - Carcinoid tumors - History of other malignancies within the past 3 years, with the exception of non-melanoma skin cancer, superficial bladder cancer, and carcinoma in situ of the cervix - Actively receiving treatment for other malignancies - Cases of lobectomy in conjunction with segmentectomy from another lobe and ≥2 segmentectomies from different lobes either en bloc or separate will be excluded from the primary analysis. - Multi-segmental resection from the same lobe is not a criterion for exclusion.

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Participants with Lung Cancer Participants undergoing planned pulmonary segmentectomy for primary lung cancer
  • Other: Patient-Reported Outcomes Measurement Information System
    Participants-reported outcomes will be collected using the Patient-Reported Outcomes Measurement Information System (PROMIS). PROMIS is a web-based platform developed by the National Institutes of Health. Scoring is standardized on a scale from 0 to 100, with a population mean of 50 and standard deviation of 10 units. High scores mean more of the concept being measured. This study will use PROMIS surveys assessing three domains: physical function (PROMIS bank version 2.0), pain interference (PROMIS bank version 1.1), and dyspnea severity (PROMIS bank version 1.0)
    Other names:
    • PROMIS

Recruiting Locations

Massachusetts General Hospital Cancer Center (Data Collection Only)
Boston, Massachusetts 02114
Contact:
Michael Lanuti, MD
617-726-6751

More Details

Status
Recruiting
Sponsor
Memorial Sloan Kettering Cancer Center

Study Contact

David Jones, MD
212-639-6428
jonesd2@mskcc.org